• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Ondansetron (Zofran) Injection

 Status: Currently in Shortage

 » Date first reported: No date available
 » Therapeutic Categories: Gastroenterology; Oncology; Pediatric

Aurobindo Pharma (New 03/18/2014)

Company Contact Information:
732-839-9400

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/ 2 mL SDV (NDC 55150-125-02) Available All presentations are available Demand increase for the drug
40 mg/ 20 mL MDV (NDC 55150-126-20) Available All presentations are available Demand increase for the drug

BD Rx (Reverified 09/19/2014)

Company Contact Information:
866-943-8534

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/2 mL (2 mg/mL), single-use Pre-filled syringe (Preservative-Free) (NDC 6045-103-20) Available Please check with your wholesaler for available inventory.

Bedford Laboratories (Reverified 07/09/2014)

Company Contact Information:
800-562-4797

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mL vial (NDC 55390-0121-01) Unavailable Shortage: Pending manufacturing change or addition Availability of products is updated on the Bedford Laboratories website. Other

Caraco (Reverified 10/30/2013)

Company Contact Information:
313-871-8400

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL ampules (NDC 62756-0181-01) Caraco temporarily discontinued ondansetron injection Discontinuation of the manufacture of the drug
20 mL vials (NDC 62756-0182-01) Caraco temporarily discontinued ondansetron injection Discontinuation of the manufacture of the drug

Claris Lifesciences (New 07/23/2014)

Company Contact Information:
877-725-2747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL Single Dose (NDC 36000-012-25) Available
20 mL Multi-Dose (NDC 36000-013-01) Available

Fresenius Kabi USA, LLC (Revised 09/11/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg; 2 mL (NDC 63323-0373-02) Available. Check wholesalers for inventory. Demand increase for the drug
40 mg; 20 mL (NDC 63323-0374-20) 6 month dating available by request. Check wholesalers for inventory. Demand increase for the drug

GlaxoSmithKline (Reverified 11/04/2013)

Company Contact Information:
888-825-5249

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Zofran injection, 2 mg/mL, 2 mL vials, packages of 5 (NDC 00173-00442-02) Discontinued GlaxoSmithKline has the following available: 20 mL vial (NDC 00173-0442-00) GlaxoSmithKline has discontinued Zofran 2 mL vials Demand increase for the drug
20 mL vial (NDC 00173-0442-00) Available GlaxoSmithKline has the following available: 20 mL vial (NDC 00173-0442-00) GlaxoSmithKline has discontinued Zofran 2 mL vials Demand increase for the drug

Heritage Pharmaceuticals Inc. (New 07/23/2014)

Company Contact Information:
866-901-3784

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL Pack of 5 (NDC 23155-196-41) Available from June 2014
2 mL Pack of 10 (NDC 23155-196-42) Available from June 2014
2 mL Pack of 25 (NDC 23155-196-43) Available from June 2014
2 mL Pack of 10 (NDC 23155-378-41) Available from June 2014
2 mL Pack of 25 (NDC 23155-378-42) Available from June 2014
20 mL multidose single vials (NDC 23155-168-31) Available from June 2014
20 mL multidose vials (NDC 23155-377-31) Available from June 2014

Hospira, Inc. (Revised 09/18/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL; 2 mL vials (NDC 0409-4755-03) Available Please check with your wholesaler for available inventory. Shortage per manufacturer: Available Other
2 mg/mL; 20 mL vials (NDC 0409-4759-01) Available Please check with your wholesaler for available inventory. Shortage per manufacturer: Available Other

Mylan Institutional (Reverified 09/16/2014)

Company Contact Information:
888-258-4199

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4mg/2ml Pkg of 25 (preservative free, lated free) (NDC 67457-441-20) Unavailable. Estimated Recovery: November 2014. Demand increase for the drug
40mg/20mL x 1 MDV (NDC 67457-440-22) Unavailable. Estimated Recovery: November 2014. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 09/15/2014)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL 2mL vial (NDC 25021-777-02) Available Other
2mg/mL 20mL vial (NDC 25021-782-20) Available Demand increase for the drug

Teva Pharmaceuticals (Reverified 09/11/2014)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mL vials (NDC 00703-7226-01) 20 ml cannot estimate a release date Demand increase for the drug
20 mL vials (NDC 00703-7226-03) 20 ml cannot estimate a release date Demand increase for the drug
2 mL vials (NDC 00703-7221-04) 2 ml has returned to supply Demand increase for the drug

West-Ward Pharmaceuticals (Reverified 08/18/2014)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 2 mL vial (NDC 0641-6078-25) West-Ward has sufficient inventory available for both presentations. West-Ward has accelerated production on this product. West-Ward is anticipating having additional product available for release in the September - October 2014 timeframe. Product will be made available as it is released. Demand increase for the drug
2 mg/mL, 20 mL Vial (NDC 0641-6079-01) West-Ward has sufficient inventory available for both presentations. West-Ward has accelerated production on this product. West-Ward is anticipating having additional product available for release in the September - October 2014 timeframe. Product will be made available as it is released. Demand increase for the drug

Wockhardt (Reverified 09/10/2014)

Company Contact Information:
800-346-6854

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 2 mL vials, package of 5 (NDC 64679-0726-01) No estimated release date available. Requirements related to compliance with manufacturing best practices
2 mg/mL, 20 mL vials, package of 1 (NDC 64679-0727-01) No estimated release date available. Requirements related to compliance with manufacturing best practices
-
-